|Articles|December 9, 2015
ICON Chooses goBalto for Study Startup
ICON is using Activate for all global studies, which span more than 50 countries.
Advertisement
goBalto announced that ICON has chosen goBalto’s flagship product Activate to bolster ICON’s clinical study startup process on a worldwide basis. ICON is using Activate for all global studies, which span more than 50 countries. ICON has already integrated Activate with its CTMS and data warehouse, and has plans to integrate with its eTMF system.
Read the full
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention
3
ACT Brief: AI-Driven Enrollment Results, Statistician Standards in Early Phase, and RNA Editing for Kidney Disease
4
SCOPE X: The COPD Case Study That Shows What AI Can Do for Enrollment
5